Lovelace, John
Lovelace, John was paid $158K by Medicaid between Jan 2020 and Oct 2022, across 6 billing codes. Its largest line is 92004, Ophthalmological services: medical examination and evaluation, comprehensive, new patient — 38% of everything it billed.
33Billing provider infoLOVELACE, JOHN
GREENVILLE, TX 75402
GREENVILLE, TX 75402
33aNPI1497802698assigned 01/03/2007
33bProvider typeOptometrist
28Total paid$158K
24GClaims3,271
24DCodes billed6
24AFirst – last monthJan 2020 – Oct 2022
Compared with peers
Next to other Optometrist providers in Texas
Rank by total paid#283 of 1,408
Median peer was paid$30K
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 334 | $17K | |
| 2021 | 2,102 | $96K | |
| 2022 | 835 | $45K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 38% | 566 | 555 | $60K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 35% | 614 | 597 | $55K |
| V2020 | Frames, purchases | 13% | 652 | 351 | $21K |
| 92015 | Determination of refractive state | 8.9% | 1,071 | 1,049 | $14K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 4.3% | 342 | 312 | $7K |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 26 | 23 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.